The first comprehensive text on dyslipidemia from a major academic institution, this book covers all aspects of dyslipidemia as it relates to human disease, including coronary artery disease, cerebrovascular disease, peripheral vascular disease, and pancreatitis. The material is presented in a clinician-friendly format and includes references for additional reading. Reflecting current guidelines from the National Cholesterol Education Program, the book explains why, when, and how to treat dyslipidemia. Coverage includes dietary treatment, drug treatment, and recommendations for special populations such as patients with coronary heart disease, patients at high risk for coronary heart disease, patients with diabetes, women, older adults, young adults, and racial and ethnic groups.
SECTION I FUNDAMENTAL ASPECTS OF DYSLIPIDEMIA AND ATHEROSCLEROSIS Chapter 1: Lipid, Apolipoprotein, and Lipoprotein Metabolism: Implications for the Diagnosis of Dyslipidemia Chapter 2: Measurement of Lipids, Lipoproteins, and Apolipoproteins Chapter 3: Pathogenesis of Atherosclerosis and the Unstable Plaque Chapter 4: Pathophysiology and Vascular Biology of Atherosclerosis Chapter 5: Clinical Trial Evidence for Treatment of Dyslipidemia in the Prevention of Cardiovascular Disease Chapter 6: Use of Noninvasive Methods to Diagnose Cardiovascular Disease in Dyslipidemic Patients SECTION II METABOLIC DISORDERS OF DYSLIPIDEMIA Chapter 7: Disorders of Hypertriglyceridemia Chapter 8: Disorders of LDL Metabolism Chapter 9: Disorders of HDL Metabolism SECTION III DYSLIPIDEMIA IN SPECIAL GROUPS Chapter 10: Pathophysiology and Treatment of Dyslipidemia in Diabetes Chapter 11: Dyslipidemia in Renal Disease Chapter 12: Dyslipidemia in Children and Adolescents Chapter 13: Dyslipidemia and Atherosclerosis in Women Chapter 14: Dyslipidemia in the Elderly: Special Insights to Inform the Management Strategy SECTION IV NONTRADITIONAL RISK FACTORS AND CARDIOVASCULAR DISEASE Chapter 15: Clinical Utility of Inflammatory Markers Chapter 16: ApoB and the Atherogenic ApoB Dyslipoproteinemias Chapter 17: Other Nontraditional Risk Factors for Cardiovascular Disease Chapter 18: Lipoprotein (A): A Pleotrophic Risk Factor for Cardiovascular Disease SECTION V DIETARY AND PHARMACOLOGIC TREATMENT OF DYSLIPIDEMIA AND CARDIOVASCULAR DISEASE Chapter 19: Dietary Treatment of Dyslipidemia Chapter 20: Trans Fatty Acids, Dyslipidemia, and Cardiovascular Disease Chapter 21: Fish Oils in the Treatment of Dyslipidemia and Cardiovascular Disease Chapter 22: Effect of Exercise on Dyslipidemia Chapter 23: Pharmacologic Treatment of Dyslipidemia and Cardiovascular Disease Chapter 24: Therapeutic Options for Modifying Obesity and Cardiometabolic Risk Factors Index